Bowen Acquisition Corp 8-K

What Happened
Bowen Acquisition Corp filed an 8-K reporting that shareholders approved an amendment to the company’s Articles to extend the deadline to consummate a business combination. At an extraordinary general meeting on June 11, 2026 (record date May 16, 2026), shareholders voted to extend the date by which the company must complete a merger, share exchange, asset acquisition or similar business combination from June 14, 2026 to as late as December 31, 2026.

Key Details

• Meeting date: June 11, 2026; record date: May 16, 2026.
• Votes tabulated on the extension proposal: For 2,723,387; Against 4,376; Abstain 17; Broker non-votes 0. A total of 2,727,780 ordinary shares were represented.
• New latest deadline: December 31, 2026 (or earlier if the Board determines).
• The amendment to the Amended and Restated Memorandum and Articles of Association will be filed as Exhibit 3.1; the company is continuing efforts to satisfy remaining conditions to close its proposed business combination with Shenzhen Qianzhi BioTechnology Co. Ltd.

Why It Matters
For investors, the approved extension gives Bowen Acquisition Corp more time to close its planned business combination (the SPAC transaction) and avoid liquidation or other outcomes tied to the original June 14, 2026 deadline. The vote was overwhelmingly in favor, but closing the proposed deal remains contingent on satisfying outstanding conditions — the extension does not guarantee the transaction will close.